need2know: 12 market-moving macro triggers to watch todayA lowdown on the top macro triggers that may move market on Tuesday.
27 Mar, 2018, 08.16 AM IST
Dr Reddy's launches generic nausea drug in USThe Hyderabad-based firm launched the product after getting approval from the US Food and Drug Administration, Dr Reddy's Labs said in a st...
26 Mar, 2018, 02.40 PM IST
Stocks in focus on 26 March 2018Here is a list of top stocks that are likely to be in focus in today's trading session.
26 Mar, 2018, 09.10 AM IST
ETMarkets After Hours: Cadila, DRL steal the show; FMCG stocks underperformShares of Cadila soared over 22% on Thursday’s after the company informed BSE that USFDA issued no observation against the company’s Moraiy...
16 Feb, 2017, 05.32 PM IST
DRL gets adverse ruling in US over patent infringement case"We are disappointed in the decision and intend to pursue an appeal in due course," a company spokesperson said.
16 Feb, 2017, 03.57 PM IST
Dr Reddy’s hits fresh 52-week low after patent infringement confirmationThe scrip was trading 2.07 per cent lower at Rs 2849.85. Shares of the company opened at Rs 2920 and touched a high and low of Rs 2932 and ...
16 Feb, 2017, 10.05 AM IST
Dr Reddy's Lab surges 6% on USFDA nod for Aloxi genericReacting to the development, the scrip gained 3.63 per cent to hit a high of Rs 3,125 on the BSE.
03 Mar, 2016, 03.57 PM IST
Helsinn Healthcare in settlement agreement with Dr Reddy'sAccording to a statement by the drug maker, Aloxi is currently distributed by Helsinn Healthcare's marketing partner, Eisai Inc in the USA.
13 Oct, 2015, 02.57 PM IST